Propanc Biopharma, Inc. (PPCB): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2013-06-30, while the company's latest annual report covers the year ended 2025-06-30. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$1.36M

Year ended 2013-06-30

2011-06-30 EBITDA (USD) 2013-06-30

Period ended	EBITDA	Change YoY	Source filing
2013-06-30	-$1.36M	n/m	2014-10-14, From 2012-07-01
2012-06-30	-$11.59M	n/m	2013-10-15, From 2011-07-01
2011-06-30	-$2.23M	n/a	2012-10-15, From 2010-07-01